These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 19706638)
1. Empty handed: a call for an international registry of risk stratification to reduce the 'sudden-ness' of death in patients with non-compaction cardiomyopathy. Caliskan K; Kardos A; Szili-Torok T Europace; 2009 Sep; 11(9):1138-9. PubMed ID: 19706638 [No Abstract] [Full Text] [Related]
2. Preventing sudden death in patients with cardiomyopathies. Li A; Zaidi A; Camm AJ Practitioner; 2007 Jun; 251(1695):44, 49-51, 53-4 passim. PubMed ID: 17654875 [No Abstract] [Full Text] [Related]
3. Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation? Plummer C Europace; 2009 Mar; 11(3):273-5. PubMed ID: 19164361 [No Abstract] [Full Text] [Related]
4. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ Circulation; 2010 Jan; 121(3):445-56. PubMed ID: 20100987 [No Abstract] [Full Text] [Related]
5. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?]. Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303 [TBL] [Abstract][Full Text] [Related]
13. Risk stratification using T-wave alternans: more questions waiting to be answered. Hohnloser SH J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1043-4. PubMed ID: 18479332 [No Abstract] [Full Text] [Related]
14. [Epidemiology of sudden cardiac death]. Andresen D Herzschrittmacherther Elektrophysiol; 2005 Jun; 16(2):73-7. PubMed ID: 15997353 [TBL] [Abstract][Full Text] [Related]
15. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591 [TBL] [Abstract][Full Text] [Related]
16. Fatal left-dominant arrhythmogenic cardiomyopathy involving a 25-year old professional football player: could it have been prevented? Busardò FP; Cappato R; D'Ovidio C; Frati P; Riezzo I; Fineschi V Int J Cardiol; 2014 Jun; 174(2):423-5. PubMed ID: 24768383 [No Abstract] [Full Text] [Related]
17. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features. Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616 [No Abstract] [Full Text] [Related]